Dohrn, Maike F. http://orcid.org/0000-0002-5320-9807
Heller, Corina
Zengeler, Diana
Obermaier, Carolin D. http://orcid.org/0000-0001-6653-8215
Biskup, Saskia
Weis, Joachim
Nikolin, Stefan
Claeys, Kristl G.
Schöne, Ulrike
Beijer, Danique http://orcid.org/0000-0001-6593-7644
Winter, Natalie
Achenbach, Pascal
Gess, Burkhard
Schulz, Jörg B.
Mulahasanovic, Lejla
Article History
Received: 10 November 2021
Accepted: 30 December 2021
First Online: 1 February 2022
Declarations
:
: We obtained the patients’ written consent for molecular genetic analyses and further scientific use, as well as for publication.
: Maike F. Dohrn has received scientific funding from Pfizer (ASPIRE 2018), has served as a paid consultant for Amicus, Akcea, Alnylam, and Pfizer, and is currently receiving a scholarship for a research fellowship by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). Jörg B. Schulz serves at advisory boards for Biogen and Roche. Burkhard Gess received financial support from Pfizer, Grifols, and Bayer for conference contributions. Natalie Winter has received scientific funding from Pfizer (ASPIRE 2018), has served as a paid consultant for Canon and Pfizer, and is currently receiving an intramural scholarship for a research fellowship (Clinician Scientist). CH, DZ, CDO, SB, JW, KGC, US, PA, and LM have no conflicts to disclose.